Utama › Hipertensi Pulmonari › Utah
Kajian klinikal Hipertensi Pulmonari di Utah
7 kajian untuk Hipertensi Pulmonari sedang mencari peserta di lokasi di Utah.
Bandar di Utah
Teks kajian rasmi (Bahasa Inggeris)
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA025, Salt Lake City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07179380Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Utah, Salt Lake City
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Intermountain Medical Center, Murray
- University of Utah Health, Salt Lake City
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06388421De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
- University of Utah & Primary Children's Hospital (Utah-PCH), Salt Lake City
Mengambil pesertaFasa 4
0 Months – 1 Month · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT05213676Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of Utah Hospital, Salt Lake City
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jun 2026 · NCT06526195Pulmonary Hypertension Association Registry
- University of Utah Health, Salt Lake City
Mengambil pesertaKajian pemerhatian
Umur 0 ke atas · Semua jantina · Dikemas kini 14 Nov 2025 · NCT04071327A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
- Primary Children's Hospital, Salt Lake City
Mengambil pesertaFasa 2
Semua umur · Semua jantina · Dikemas kini 4 Apr 2025 · NCT05201144Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.